Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Nitric Oxide for Preterm Infants
NCT00016523Phase 3Terminated
- Sponsor
- NICHD Neonatal Research Network
- Start
- Jan 2001
- Primary completion
- Sep 2003
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in respiratory failure comparing Inhaled Nitric Oxide with Placebo (2 arms). Primary endpoint: Death or Bronchopulmonary Dysplasia. Started Jan 2001; status: terminated.
02
Drugs
nitric oxide
03
Conditions
respiratory failure
Beyond the preview
Go deeper on NCT00016523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00016523.